• Google

    FY2019 EPS Estimates for Sarepta Therapeutics Inc (SRPT) Lowered by William Blair /Link

    Sarepta Therapeutics Inc (NASDAQ:SRPT) – Investment analysts at William Blair decreased their FY2019 earnings estimates for shares of Sarepta Therapeutics in a research note issued to investors on Monday, October 15th. William Blair analyst T. Lugo now anticipates that the biotechnology company will post earnings per share of ($1.74) for the year, down from their […]

    (@)Ron Greene

    Published on 20 Oct 2018 at 10:32AM

    Earnings History and Estimates for Sarepta Therapeutics (NASDAQ:SRPT) Helmerich & Payne  Rating Lowered to Hold at Zacks Investment Research Sierra Oncology  Lowered to Sell at Zacks Investment Research Carvana  Given a $52.00 Price Target at Wedbush Head to Head Comparison: USA Compression Partners  & Rice Midstream Partners Supervalu  Rating Increased to Hold at Zacks Investment Research Web Analytics share news on Facebook tweet this investment news share on linkedin share on StockTwits share on Google Plus share on reddit

  • Recent Posts